1011866
ClinicalTrials.gov NCT02548351
Research payments
$21,056,838
Through program year 2020, $21,056,838 in research payments was reported against 1011866, across 3,783 payments, paid by Intercept Pharmaceuticals, Inc..
- Paid by
- Intercept Pharmaceuticals, Inc.
- ClinicalTrials.gov
- NCT02548351
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $7,689,654 | 1,646 |
| 2019 | Research | $13,367,184 | 2,137 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Robert Falcone Whitehouse Station, NJ Named on 140 payments
- Anita Kohli Chandler, AZ Named on 80 payments
- Moises Nevah Rubin Houston, TX Named on 75 payments
- Jason Wilson Charlotte, NC Named on 66 payments
- Eva-Maria Heurich Orlando, FL Named on 65 payments
- Apurva Modi Fort Worth, TX Named on 65 payments
- Joe Pouzar Houston, TX Named on 64 payments
- Joel Solis McAllen, TX Named on 57 payments
- Samuel Sigal New York, NY Named on 56 payments
- Bob Souder Jackson, TN Named on 53 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.